These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11623946)

  • 21. Tobacco, public health, and the FDA.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Jul; 361(4):402-3. PubMed ID: 19546344
    [No Abstract]   [Full Text] [Related]  

  • 22. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 23. Fifty years of drug amendments revisited: in easy-to-swallow capsule form.
    Kaplan AH
    Food Drug Law J; 1995; 50 Spec():179-96. PubMed ID: 10343042
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics, big business, and consumers. The context of government investigations into the postwar American drug industry.
    Bud R
    Technol Cult; 2005 Apr; 46(2):329-49. PubMed ID: 16116706
    [No Abstract]   [Full Text] [Related]  

  • 26. James Harvey Young, PhD, (1915-2006). Historian of medical quackery.
    Marcus DM
    Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):16-21. PubMed ID: 18767597
    [No Abstract]   [Full Text] [Related]  

  • 27. James Harvey Young and medical education.
    Turton FE
    Pharos Alpha Omega Alpha Honor Med Soc; 2009; ():58. PubMed ID: 19263656
    [No Abstract]   [Full Text] [Related]  

  • 28. The History of the FDA's Fight for Consumer Protection and Public Health, by US Food and Drug Administration.
    Semler E
    Nurs Hist Rev; 2020 Sep; 28(1):199-202. PubMed ID: 31537731
    [No Abstract]   [Full Text] [Related]  

  • 29. [Control service during 50 years of Soviet Public Health].
    Bushkova MM
    Farm Zh; 1968; 23(5):17-21. PubMed ID: 4889514
    [No Abstract]   [Full Text] [Related]  

  • 30. Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority.
    Plank LS
    J Midwifery Womens Health; 2011; 56(3):198-204. PubMed ID: 21535368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public health and the law: A bicentennial review.
    Curran WJ
    Am J Public Health; 1976 Jan; 66(1):93-4. PubMed ID: 1108683
    [No Abstract]   [Full Text] [Related]  

  • 32. Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration.
    Oram M
    Hist Psychiatry; 2016 Sep; 27(3):290-306. PubMed ID: 27194113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Framing processes in public commentary on US federal tobacco control regulation.
    Roth AL; Dunsby J; Bero LA
    Soc Stud Sci; 2003 Feb; 33(1):7-44. PubMed ID: 12918520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The doctor's responsibility and risk in the prescribing of drugs].
    Aschenbrenner R
    Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
    [No Abstract]   [Full Text] [Related]  

  • 35. Who is the guilty party? Rights, motherhood, and the problem of prenatal drug exposure.
    Zivi KD
    Law Soc Rev; 2000; 34(1):237-58. PubMed ID: 17094216
    [No Abstract]   [Full Text] [Related]  

  • 36. Will congressional action go up in smoke? Overcoming obstacles in granting the FDA jurisdiction over tobacco products.
    Kamensky DB
    Georgetown Law J; 1998 Jul; 86(7):2677-701. PubMed ID: 10343052
    [No Abstract]   [Full Text] [Related]  

  • 37. Obesity--the new frontier of public health law.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2006 Jun; 354(24):2601-10. PubMed ID: 16775242
    [No Abstract]   [Full Text] [Related]  

  • 38. History and application of drug safety and efficacy requirements in the United States.
    Wardell WM
    Agents Actions; 1978 Jun; 8(4):420-1. PubMed ID: 356565
    [No Abstract]   [Full Text] [Related]  

  • 39. The redemption of thalidomide: standardizing the risk of birth defects.
    Timmermans S; Leiter V
    Soc Stud Sci; 2000 Feb; 30(1):41-71. PubMed ID: 11624679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signs, marks, and private parts: doctors, legal discourses, and evidence of rape in the United States, 1823-1930.
    Robertson S
    J Hist Sex; 1998 Jan; 8(3):345-88. PubMed ID: 11620018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.